Dr. Gurvinder Singh Rekhi, Academic Professional Associate, has been issued a US patent for “Controlled Release Combinations Comprising a Combination of Isosorbide Dinitrate and Hydralazine Hydrochloride”. US Patent 9,308,177 B2, April 12, 2016. Inventors – Gurvinder Singh Rekhi, Richard Sidwell and Sharon Hamm.
Dr. Rekhi was also invited to attend a two-day forum on “Assuring Patient Safety: The Pharmaceutical Industry’s Challenges and Steps toward Ensuring Drug Quality” organized by Waters Corporation – May 18-19, 2016, University of Maryland School of Pharmacy, Baltimore, Maryland.
Congratulations, Dr. Rekhi!